American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Politics

Top 3 underappreciated Asian stocks to buy in 2025

by admin November 24, 2024
November 24, 2024
Top 3 underappreciated Asian stocks to buy in 2025

HSBC expects a “raft of stocks” to benefit from Southeast Asian investments in infrastructure, a slowing Indian economy, and China’s stimulus blitz in 2025.

In particular, the investment firm sees Kia Corp, Meituan, and Krishna Institute of Medical Sciences as high-quality, underappreciated names that are “best positioned to capture growth from these opportunities.”

Let’s take a look at what each of these three has in store for investors.

Kia Corp (KRX: 000270)

HSBC dubs Kia stock the “best value play for 2025” as investors are yet to fully appreciate just how competitive this Korean automaker is in EVs and hybrid vehicles space.

Its analyst Will Cho expects Kia to tap on its strong margin profile to launch more competitive and affordable electric vehicles next year. Kia opened its first factory focused on EV production in October.

The investment firm expects any potential weakness in the US due to Trump’s policies to be largely offset by market share gains in the EU region.

Will Cho’s buy recommendation on Kia shares coupled with a price target of 160,000 Korean won translates to a 64% upside from here.

Krishna Institute of Medical Sciences (NSE: KIMS)

HSBC expects Krishna Institute of Medical Sciences to benefit next year as Indians continue to invest in quality health care.

The investment firm sees KIMS as a “best-in-class small-cap” Asian stock that is particularly “well positioned to sustain healthy growth” rates over the long term.  

Krishna Institute has moved into high-end procedures including transplants and oncology and is exploring newer markets to unlock new avenues for future growth. It has also committed to expanding its bed capacity by an exciting 60% over the next three years.

Together, these moves will help the company “sustain healthy margins by improving its revenue mix,” as per HSBC.

The investment firm has a 670 INR price target on KIMS that indicates potential for about a 14% upside from here.

Meituan (HKG: 3690)

HSBC recommends investing in Meituan as it’s a “best-in-class large cap” that stands to meaningfully benefit from China’s new policy measures.

The investment firm likes this name as it has remained resilient in the face of macro challenges. “High-quality growth, improving profitability, and limited competition” were among the reasons HSBC cited this week in his bullish note.

Analysts at the firm expect Meituan to grow its top line by 20% this year and another 17% in 2025. “Its earnings quality is one of the best in the sector,” they added.

Compared to its internet peers, Meituan is “relatively under-owned” at writing. Less than half of the global emerging market funds currently own this stock versus “two out of every three funds” for Tencent.

HSBC has a 220 Hong Kong dollar price target on Meituan stock that suggests it could rally up to 30% from here.

The post Top 3 underappreciated Asian stocks to buy in 2025 appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Dow Jones, S&P 500 rise on strong US manufacturing data; Gap jumps 15%, while Alphabet and NVIDIA slide
next post
Survey reveals $270K salary seen as key to financial success in the US, but many fall short

Related Posts

Stoxx 600 index top laggards and gainers in...

December 29, 2024

Populists shut out of European political systems that...

July 21, 2024

What made Cipher Mining (CIFR) stock rally 30%...

February 1, 2025

The many flavors of Ben & Jerry’s corporate...

November 17, 2024

Nancy Pelosi, John Kerry, other Biden allies awarded...

May 5, 2024

Biden needs to learn from Carter about standing...

February 20, 2024

JD Vance slams NY v. Trump trial as...

May 14, 2024

Trump expected back in court for classified documents...

February 13, 2024

White House says it was Biden’s idea to...

February 14, 2024

Supreme Court agrees to review whether Trump immune...

February 29, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Oil prices face litmus test as US-Iran nuclear talks, OPEC meeting to shape market next week

      June 29, 2025
    • GMS stock jumps 29% on takeover interest from Home Depot, QXO, analysts raise PTs

      June 22, 2025
    • Japan’s rice price surge: what’s driving it and why it could spark a political crisis

      June 22, 2025
    • BofA raises STOXX 600 target amid resilient global growth, warns on Mideast risks

      June 22, 2025
    • Palantir co-founder: US must prevent Iranian nukes

      June 22, 2025

    Categories

    • Business (3,255)
    • Investing (2,558)
    • Latest News (2,001)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved